150344-44-8

Basic information

• Product Name: 2-Chlorobenzyl-4-fluorophenyl ketone
• Synonyms: 2-Chlorobenzyl-4-fluorophenyl ketone
• CAS NO: 150344-44-8
• Molecular Formula: C₁₄H₁₀ClFO
• Molecular Weight: 467.3340264
• Mol File: 150344-44-8.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-Chlorobenzyl-4-fluorophenyl ketone(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Chlorobenzyl-4-fluorophenyl ketone(150344-44-8)
• EPA Substance Registry System: 2-Chlorobenzyl-4-fluorophenyl ketone(150344-44-8)

Safety Data

• Hazardous Substances Data: 150344-44-8(Hazardous Substances Data)

Downstream Products

• 94147-99-6 2-(2-Chloro-phenyl)-1-(4-fluoro-phenyl)-2-hydroxy-3-[1,2,4]triazol-1-yl-propan-1-one 
• 107710-87-2 2-(2-Chloro-phenyl)-1-(4-fluoro-phenyl)-2-hydroxy-3-[1,2,4]triazol-4-yl-propan-1-one 
• 107680-18-2 (2R,3R)-2-(2-Chloro-phenyl)-3-(4-fluoro-phenyl)-1-[1,2,4]triazol-1-yl-butane-2,3-diol 
• 107680-17-1 (2R,3S)-2-(2-Chloro-phenyl)-3-(4-fluoro-phenyl)-1-[1,2,4]triazol-1-yl-butane-2,3-diol 
• 107680-24-0 (2R,3S)-2-(2-Chloro-phenyl)-3-(4-fluoro-phenyl)-1-[1,2,4]triazol-1-yl-heptane-2,3-diol 
• 107680-25-1 (2R,3R)-2-(2-Chloro-phenyl)-3-(4-fluoro-phenyl)-1-[1,2,4]triazol-1-yl-heptane-2,3-diol 
• 135319-73-2 1-((3-(2-chlorophenyl)-2-(4-fluorophenyl)oxiran-2-yl)methyl)-1H-1,2,4-triazole 

Relevant articles and documents

Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation

Compounds of formula (I): STR1 wherein: R1 is hydrogen, alkyl, halogen, haloalkyl, hydroxy, alkoxy, haloalkoxy, alkylthio, haloalkylthio, amino, alkanoyl, haloalkanoyl, carboxy, alkoxycarbonyl, carbamoyl, cyano, nitro, alkanesulfonyl, haloalkanesulfonyl or sulfamoyl; R2 is optionally substituted alkanoyl, optionally substituted alkenoyl, optionally substituted cycloalkylcarbonyl, substituted benzoyl, or 5,6-dihydro-1,4,2-dioxazin-3-yl; R3 is hydrogen, hydroxy, optionally substituted alkoxy, aralkyloxy, alkanoyloxy, alkenoyloxy, cycloalkylcarbonyloxy, arylcarbonyloxy, alkoxycarbonyloxy, aralkyloxycarbonylxy, phthalidyloxy, (5-methyl-2-oxo-1,3-dioxolen-4-yl)methoxy, (5-phenyl-2-oxo-1,3-dioxolen-4-yl)methoxy, optionally substituted amino or nitro; Y is --NH-- or oxygen or sulfur; n is 1 to 5; and tautomers and salts of said compounds of formula (I), have the ability to inhibit blood platelet aggregation, and can thus be used for treatment and prophylaxis of thrombosis and embolisms.